Kestra Medical Techs Q4 EPS $(2.21), Sales $17.233M Beat $15.752M Estimate

Kestra Medical Techs (NASDAQ: KMTS) reported quarterly losses of $(2.21) per share which missed the analyst consensus estimate of $(0.56) by 294.64 percent. The company reported quarterly sales of $17.233 million which beat the analyst consensus estimate of $15.752 million by 9.40 percent.